Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 06:16 am Purchase |
2024-02-02 | 13G | Nuvve Holding Corp. NVVE |
Mitchell P. Kopin | 41,100 8.900% |
41,100 (New Position) |
Filing History |
| 2024-02-06 11:12 am Purchase |
2023-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Mitchell P. Kopin | 814,383 1.800% |
787,291 (+2905.99%) |
Filing History |
| 2024-02-06 10:30 am Purchase |
2023-12-31 | 13G | OceanPal Inc. OP |
Mitchell P. Kopin | 105,655 1.400% |
105,655 (New Position) |
Filing History |
| 2024-02-06 10:30 am Purchase |
2023-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 99,045 9.990% |
99,045 (New Position) |
Filing History |
| 2024-02-06 10:29 am Purchase |
2023-12-31 | 13G | Palisade Bio, Inc. PALI |
Mitchell P. Kopin | 12,035 1.900% |
3,296 (+37.72%) |
Filing History |
| 2024-02-06 10:27 am Sale |
2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Mitchell P. Kopin | 13,012 1.500% |
-6,185 (-32.22%) |
Filing History |
| 2024-02-06 10:24 am Unchanged |
2023-12-31 | 13G | NAYA Biosciences, Inc. NAYA |
Mitchell P. Kopin | 15,333 6.900% |
0 (Unchanged) |
Filing History |
| 2024-02-06 10:24 am Purchase |
2023-12-31 | 13G | Performance Shipping Inc. PSHG |
Mitchell P. Kopin | 472,800 3.900% |
206,134 (+77.30%) |
Filing History |
| 2024-02-06 10:23 am Sale |
2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 6,191 6.600% |
-495 (-7.40%) |
Filing History |
| 2024-02-06 10:22 am Purchase |
2023-12-31 | 13G | Helius Medical Technologies, Inc. HSDT |
Mitchell P. Kopin | 1 0.100% |
1 (New Position) |
Filing History |
| 2024-02-06 10:19 am Purchase |
2023-12-31 | 13G | Guardion Health Sciences, Inc. GHSI |
Mitchell P. Kopin | 50,000 3.800% |
50,000 (New Position) |
Filing History |
| 2024-02-06 10:17 am Sale |
2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 644 6.200% |
-272 (-29.66%) |
Filing History |
| 2024-02-06 10:16 am Purchase |
2023-12-31 | 13G | Synaptogenix, Inc. SNPX |
Mitchell P. Kopin | 41,929 4.990% |
10,460 (+33.24%) |
Filing History |
| 2024-02-06 10:14 am Purchase |
2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Mitchell P. Kopin | 23,961 0.900% |
23,961 (New Position) |
Filing History |
| 2024-02-06 10:12 am Unchanged |
2023-12-31 | 13G | Tian Ruixiang Holdings Ltd TIRX |
Mitchell P. Kopin | 53,667 8.100% |
0 (Unchanged) |
Filing History |
| 2024-02-06 10:11 am Purchase |
2023-12-31 | 13G | Antelope Enterprise Holdings Limited AEHL |
Mitchell P. Kopin | 2,751 4.990% |
2,751 (New Position) |
Filing History |
| 2024-02-06 10:06 am Purchase |
2023-12-31 | 13G | Aditxt, Inc. ADTX |
Mitchell P. Kopin | 1 1.500% |
1 (New Position) |
Filing History |
| 2024-02-06 10:04 am Unchanged |
2023-12-31 | 13G | DMK Pharmaceuticals Corporation DMKPQ |
Mitchell P. Kopin | 650,000 6.000% |
0 (Unchanged) |
Filing History |
| 2024-02-06 09:56 am Sale |
2023-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 903,412 9.990% |
-1,015,547 (-52.92%) |
Filing History |
| 2024-02-06 09:52 am Purchase |
2023-12-31 | 13G | Clearmind Medicine Inc. CMND |
Mitchell P. Kopin | 88,925 4.990% |
88,925 (New Position) |
Filing History |